BridgeMD
New treatment option for Autism Disorder
Official title Impact and Determinants of Success of a Mobile Multidisciplinary Intervention System Specialized in Pain Management for Patients With Moderate to Severe Intellectual Development Disorder, Isolated or Associated With an ASD or Multiple Disability
ClinicalTrials.gov ID: NCT07302048
What this study is testing
- What it's testing
- Pain is described by patients with a Neurodevelopmental Disorder (NDD), including Autism Spectrum Disorder (ASD), Intellectual Development Disorder (IDD) or multiple disabilities, and the family as one of the main associated disorders; its management is also one of the main concerns of families and professionals. At present, there is no validated and tested pain management system in populations facing complex pain situations.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages up to 24
You may be able to join if
- Aged from birth up to 24 years inclusive (i.e., under 25 years old)
- Medical diagnosis of intellectual disability (ID), isolated or associated with autism spectrum disorder (ASD), developmental disorder (DD), or...
- Confirmed probable or definite pain diagnosis, as validated by the MoDIDol team
- PGIC score ≥ 3
- Living in or receiving care in the departments of Finistère, Côtes-d'Armor, or Morbihan
You likely can't join if
- More than three places of residence and/or care settings
- Parents or legal guardians who do not have sufficient language or comprehension skills to provide informed consent or complete study questionnaires
See the full eligibility criteria
- Aged from birth up to 24 years inclusive (i.e., under 25 years old)
- Medical diagnosis of intellectual disability (ID), isolated or associated with autism spectrum disorder (ASD), developmental disorder (DD), or profound multiple disabilities, based on international classification...
- Confirmed probable or definite pain diagnosis, as validated by the MoDIDol team
- PGIC score ≥ 3
- Living in or receiving care in the departments of Finistère, Côtes-d'Armor, or Morbihan
- Written informed consent provided by parents, legal guardians, or holders of parental authority, authorizing data collection for research and publication purposes
- Affiliated with or benefiting from a French national health insurance scheme
- More than three places of residence and/or care settings
- Parents or legal guardians who do not have sufficient language or comprehension skills to provide informed consent or complete study questionnaires
The study team makes the final eligibility decision.
Where it's taking place
- Brest, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, up to 24 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brest, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.